Real‐World Experience With Control‐IQ Technology in Saudi Children With Insulin‐Dependent Diabetes: A Single‐Center Observational Study
Authors' conclusion
The findings demonstrated that Control-IQ technology is both effective and safe in improving glycemic outcomes in children with insulin-dependent diabetes in a real-world clinical setting. However, successful implementation requires comprehensive training and continuous support.
Study context
- Population
- Children aged 2–14 years with insulin-dependent diabetes transitioning from MDI to Control-IQ, King Faisal Specialist Hospital and Research Centre (KFSHRC) diabetes clinic, Saudi Arabia; median age 11 years; 82% history of severe hypoglycaemia44 boys · 56 girls
- Participants
- 100 children
- Exposure
- Control-IQ automated insulin delivery (AID) after transition from MDI vs baseline
- Outcome
- Change in HbA1c
- Follow-up
- 6 months after initiating Control-IQ
Methodological detailssingle-centre, real-world
- Single-centre
- Real-world
Main finding
As reported in the abstract
Median HbA1c, baseline to 6 months
Median HbA1c baseline → 6 months
9.2% to 6.9%
Change in median HbA1c
−25.0%
p < 0.001
Observational data: associations, not effects.
Further findings
Daily insulin dose · 6 months
- Reduction in daily insulin dose
- 24.4%
Time in range (TIR) (70-180 mg/dL)
- TIR baseline → follow-up
- 45.6% to 68.8%
- Change in TIR
- +23.2%; p < 0.001
Time in significant hypoglycaemia (<54 mg/dL)
- Decrease in time <54 mg/dL
- 88.9%; p < 0.001
TIR targets achieved · 6 months
- Achieved ≥60% TIR
- 83%
- Achieved ≥70% TIR
- 54%
Adherence and engagement
- Adherence and engagement were high; no discontinuations
Safety
Safety · 6 months
- Mild/moderate ketoacidosis due to technical issues in the Control-IQ
- 3%
- No severe hypoglycemia or discontinuations
Original publication
Real‐World Experience With Control‐IQ Technology in Saudi Children With Insulin‐Dependent Diabetes: A Single‐Center Observational Study. Pediatr Diabetes. Published 1 March 2026. doi:10. 1155/ pedi/ 6113065
Composed by AI from the published abstract and checked against it. How Briefs are made →